ArticleScientific reports2026
Structural investigation, theoretical and biological studies of 8-hydroxyquinoline azo ligand and its metal chelates.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the current work, three novel bimetallic Ni(II), Cd(II), and Pt(II) complexes of the azo dye ligand with the name 5-(2,6-dimethyl-pyrimidin-4-ylazo)-quinolin-8-ol were planned as our target for synthesis and application in the medicinal field. The free ligand and the synthesized metal complexes were subjected to all the available analytical and spectral tools to get a clear and correct insight into their structures and geometries. Such tools supported the formation of bimetallic complexes with 4-coordination geometry, as assured from the results of elemental analysis, mass, infrared (IR) spectroscopy, and thermal analysis. Magnetic moment of 2.87 B.M for Ni(II) complex (per one Ni centre) along with UV-Vis spectra assured its tetrahedral geometry. Cd(II) complex was found to be tetrahedral, and Pt(II) complex is square planar. Biological evaluations demonstrated significant anticancer and antibacterial efficacy of most of the tested compounds. The highest activity as antimicrobial agent was afforded by the ligand, showing an inhibition zone diameter of 51 and 52 mm against Aspergillus fumigatus and Bacillus subtilis, respectively, showing higher activity than the metal complexes. The Cd(II) exhibited the highest efficacy, among all the tested compounds, toward both screened tumor cell lines (yielding IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.